Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
about
First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic optionsRole of trastuzumab emtansine in the treatment of HER2-positive breast cancerBreast cancer brain metastases: biology and new clinical perspectivesEnhanced anticancer activity of DM1-loaded star-shaped folate-core PLA-TPGS nanoparticlesBrain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up.Activity of T-DM1 in HER-2 positive central nervous system breast cancer metastasesEmerging strategies for treating brain metastases from breast cancer.Unsanctifying the sanctuary: challenges and opportunities with brain metastases.Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: a report of two cases.Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain MicroenvironmentPredictive molecular markers in metastases to the central nervous system: recent advances and future avenues.Systemic therapy of brain metastases.The future of targeted therapies for brain metastases.Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.[Therapeutic options for brain metastases].Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1.Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts.ABC4 Consensus: Assessment by a German Group of Experts
P2860
Q26746081-FB7BC021-E051-42FB-83A2-B894E3341875Q26777681-637D39EE-A544-4927-9AE0-4830A1DD422FQ27003258-EC463880-0088-4A61-878F-D95E05C748A8Q28078998-D995079A-2A2D-4018-834A-4D52FFB73625Q28654503-0D730743-3B90-43C3-9190-49681332F936Q31154571-6C735B96-4A4D-45EA-85A6-83FF458E6A04Q34071514-F5188190-F333-48CF-B0CE-5E6D581888A2Q35075446-E8D31B8E-C284-423E-A5A6-3B281B5B687BQ35788631-53C5DB71-65C4-4389-8631-683F23A87CEEQ36067578-0BFC415E-8ED9-4B20-B80D-B88CA25327DFQ36372466-D76BB4CA-F80A-4029-9398-EC9B4C4E9DCCQ36887659-E45ADF1E-EF0D-467D-9DC5-8B830B6EB58FQ38257364-97053844-4346-41C5-A4ED-96764813986DQ38285931-E04B88C6-A1A1-44FC-8DBD-6B0501B44C10Q38564085-6C58B5D0-03BD-45A8-9419-0FFD8B551CA2Q38575259-32C8E607-B85D-4B19-9217-0A204199308AQ38792519-BB813D78-74E1-44B7-88DA-62FF110AD8F8Q38829087-CE17B700-1443-4EBF-83FA-B7806DEC7C9AQ39775271-C0000DB1-8EE1-4BF7-AFFF-774F3AE1C19DQ41728643-3ABF4587-BC98-4271-946F-F23626447E62Q47839509-367966F9-D270-4BBE-9385-721F9256E858Q48713634-2179D334-D435-4040-91F5-9355F7B8EFE9Q49049652-54E62153-F60B-428B-A354-3DA75354DC5DQ54118354-66ADAF74-AA12-4F5C-9B35-3FD96628C0DFQ55346396-5719A20A-5F11-49F1-A842-EDE478D91559Q56968314-CFA19FCD-61A3-431E-B38E-FF8BCEE0EBA4
P2860
Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
@en
Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
@nl
type
label
Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
@en
Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
@nl
prefLabel
Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
@en
Breast cancer brain metastases responding to primary systemic therapy with T-DM1.
@nl
P1476
Breast cancer brain metastases responding to primary systemic therapy with T-DM1
@en
P2093
Rupert Bartsch
P2860
P2888
P304
P356
10.1007/S11060-013-1257-5
P577
2013-09-25T00:00:00Z
P6179
1004972251